This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Excelmab, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Cuijuan Chen: Innovator in Cancer Treatment
Introduction
Cuijuan Chen is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies. His work focuses on addressing critical health challenges, particularly in the treatment of breast cancer.
Latest Patents
Cuijuan Chen holds a patent for a bispecific antibody and its uses. This innovative antibody targets CD3 and a tumor antigen such as HER2, providing a method for treating breast cancer. The patent outlines a preparation method and various applications of the antibody, including a composition that utilizes this antibody for cancer treatment.
Career Highlights
Chen is associated with Excelmab, Inc., where he continues to advance his research in antibody development. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from breast cancer.
Collaborations
Cuijuan Chen collaborates with notable colleagues, including Wenjun Zhang and Xuemei Wei, who contribute to his research efforts and the development of innovative cancer therapies.
Conclusion
Cuijuan Chen's contributions to the field of cancer treatment through his bispecific antibody patent highlight his role as an influential inventor. His work not only showcases his innovative spirit but also holds promise for improving patient care in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile